| Variable | Total patients | Infection | No infection | Univariate analysis | Multivariate logistic regression analysis | | | () | P value | Odds ratio (95%CI) | P value |
| Ages, mean (SD), years | 59.81 (12.71) | 59.66 (13.51) | 58.69 (12.47) | 0.113 | | | Female, % | 2034 (82.90) | 476 (86.07) | 1558 (82.04) | 0.026 | 0.70 (0.53–0.92) | 0.012 | Course of diseases, median (IQR), years | 9.00 (3.00–16.00) | 9.00 (3.00–16.00) | 9.00 (3.00–17.00) | 0.344 | | | Duration in hospital, mean (SD), days | 11.49 (5.27) | 12.31 (6.32) | 11.25 (4.89) | <.001 | 1.03 (1.01–1.05) | <.001 | Organs involved, No. mean (SD) | 3.83 (0.67) | 4.75 (0.79) | 3.85 (0.63) | 0.006 | 0.82 (0.72–0.93) | 0.003 | Comorbidities, No.mean (SD) | 0.56 (0.81) | 0.60 (0.81) | 0.54 (0.80) | 0.143 | | | DMARDs, No. mean (SD) | 1.90 (0.721) | 2.00 (0.743) | 1.87 (0.71) | <.001 | 1.22 (1.06–1.40) | 0.005 | Corticosteroids dosage, mean (SD), mg/d | 3.55 (8.43) | 4.33 (9.97) | 3.31 (7.92) | 0.027 | 1.02 (1.01–1.03) | 0.003 | Pulse CTX, % | 95 (3.87) | 31 (5.6) | 64 (3.3) | 0.017 | | | Etanercept, % | 1226 (50.00) | 263 (47.56) | 963 (50.71) | 0.192 | | | WBC counts, median (IQR), ×109/L | 6.40 (5.00–7.90) | 6.60 (2.51–8.20) | 6.38 (3.00–7.80) | 0.005 | 1.04 (1.00–1.08) | 0.051 | PLT, median (IQR), ×1012/L | 232.00 (173.00–302.00) | 236.00 (171.00–306.00) | 228.00 (174.00–302.00) | 0.557 | | | E., median (IQR), ×109/L | 0.14 (0.09–0.25) | 0.14 (0.09–0.29) | 0.14 (0.09–0.25) | 0.013 | | | HB, median (IQR), g/L | 113.00 (102.00–125.00) | 110.00 (100.00–122.00) | 114.00 (103.00–126.00) | <.001 | | | Globin, median (IQR), g/L | 30.00 (27.00–34.50) | 30.00 (26.00–34.00) | 30.10 (27.00–34.60) | 0.088 | | | ALB, median (IQR), g/L | 35.00 (30.00–39.20) | 34.00 (28.00–38.00) | 35.80 (31.00–40.00) | <.001 | 0.98 (0.97–0.99) | <.001 | ESR, median (IQR), mm/H | 36.00 (15.00–67.00) | 38.00 (17.20–76.00) | 36.00 (14.00–65.00) | 0.006 | | | CRP, median (IQR), mg/L | 8.00 (2.53–28.10) | 12.10 (.35–41.00) | 7.88 (2.28–25.3) | <.001 | 1.03 (1.02–1.04) | 0.021 | IgG, median (IQR), mg/L | 12.60 (4.76–16.00) | 12.10 (6.80–15.70) | 12.70 (2.80–16.00) | 0.873 | | | IgA, median (IQR), mg/L | 2.68 (0.87–3.70) | 2.74 (1.01–3.81) | 2.60 (0.7–3.70) | 0.356 | | | IgM, median (IQR), mg/L | 1.00 (0.20–1.64) | 1.00 (0.40–1.56) | 1.04 (0–1.67) | 0.532 | | |
|
|
Data are number (%) of patients, unless otherwise indicated. SD: standard deviation. IQR: interquartile range. CI: confidence interval. Organs involved, No.: the number of involved organs. Comorbidities, No.: the number of comorbidities: hypertension, diabetes mellitus, malignancy, chronic lung disease, congestive heart failure, cardiac arrhythmia, renal failure, liver disease. DMARDs, No.: the numbers of DMARs (disease-modifying antirheumatic drugs). WBC: white blood cell. PLT: platelet. E: eosinophils. HB: homoalbumin. ALB: albumin. ESR: erythrocyte sedimentation rate. CRP: C-reactive protein.
|